Trinity Biotech has a one year ... the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products ...

Analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the stock. Trinity ...

The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...

Trinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...

DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Trinity Biotech plc (TRIB), a leading developer of diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market, has seen its stock price touch a 52-week low, ...

The company is gearing up for regulatory submissions in Europe in 2025 and plans to file with the U.S. FDA in 2026. Trinity Biotech is also preparing for additional pre-pivotal clinical trials in ...

Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a ...

DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

The company is gearing up for regulatory submissions in Europe in 2025 and plans to file with the U.S. FDA in 2026. Trinity Biotech is also preparing for additional pre-pivotal clinical trials in Q1 ...

Trinity Biotech's two rapid HIV tests will continue to be funded under PEPFAR, a significant global initiative to combat HIV/AIDS. The company confirmed that other testing programs using their rapid ...